These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26832931)

  • 1. Opioid substitution therapy: Lowering the treatment thresholds.
    Kourounis G; Richards BD; Kyprianou E; Symeonidou E; Malliori MM; Samartzis L
    Drug Alcohol Depend; 2016 Apr; 161():1-8. PubMed ID: 26832931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
    Koller G
    Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
    Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M
    Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
    Parrino MW; Maremmani AG; Samuels PN; Maremmani I
    J Addict Dis; 2015; 34(2-3):255-62. PubMed ID: 26110357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
    McElrath K
    Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
    Casati A; Piontek D; Pfeiffer-Gerschel T
    Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
    Holbrook AM
    Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
    Dennis BB; Naji L; Bawor M; Bonner A; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Samaan Z; Thabane L
    Syst Rev; 2014 Sep; 3():105. PubMed ID: 25239213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past-year gambling behaviour among patients receiving opioid substitution treatment.
    Castrén S; Salonen AH; Alho H; Lahti T; Simojoki K
    Subst Abuse Treat Prev Policy; 2015 Jan; 10():4. PubMed ID: 25626451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.